Current Allergy and Asthma Reports

, Volume 12, Issue 6, pp 541–546 | Cite as

Rationale and Feasibility of Intranasal Delivery of Drugs to the Eustachian Tube Orifice

  • Mamun Rashid


Intranasal medication for eustachian tube dysfunction (ETD) is an established practice in otolaryngology through the effects of steroids, decongestants, antihistamines or a combination of the above in reducing tubal oedema. The author has previously argued that a double-blind, randomised control trial would be helpful in determining effectiveness of treatment, if a standardised head position, chiefly Mygind or Ragan, was adopted to maximise intranasal drop delivery into the eustachian tube orifice. One recent paper suggests that intranasal treatment is not very effective, but ultimately does not state whether a standardised head position was adopted. Although a large body of evidence supports the hypothesis that the nasal passages are the route to middle ear disease, there is as yet no paper that has been published that has specifically addressed this issue, therefore the author must conclude that evidence to support intranasal treatment for ETD is still lacking and further research is desirable.


Intranasal drugs Eustachian tube orifice Eustachian tube dysfunction Intranasal administration Head position Delivery Rationale Feasibility Allergy Otitis media Suppurative otitis media Intranasal steroids Intranasal decongestants Intranasal antihistamines Intranasal saline 



No potential conflicts of interest relevant to this article were reported.


Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. 1.
    Fireman P. Otitis media and eustachian tube dysfunction: connection to allergic rhinitis. J Allergy Clin Immunol. 1997;99:S787–97.PubMedCrossRefGoogle Scholar
  2. 2.
    Lildholdt T, Cantekin EI, Bluestone C, Rockette H. Effect of a topical nasal decongestant on Eustachian tube function in children with tympanotomy tubes. Acta Otolaryngol. 1982;94:93–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Tracy J, Dermain J, Hoffman K, Goetz D. Intranasal beclomethasone as an adjunct to the treatment of chronic middle ear effusion. Ann Allergy. 1998;80:198–206.CrossRefGoogle Scholar
  4. 4.
    Venkatayan N, Troublefield Y, Connelly P, Mautone A, Chandrasekhar S. Intranasal surfactant aerosol therapy for otitis media with effusion. Laryngoscope. 2000;110:1857–60.PubMedCrossRefGoogle Scholar
  5. 5.
    Elies W. Topical steroids in the treatment of mucosal swelling of the nasal cavity. J Chemother. 1997;6:31–4.Google Scholar
  6. 6.
    Shapiro G, Bierman C, Furukawa C, Pierson W, Berman R, Donaldson J, et al. Treatment of persistent eustachian tube dysfunction in children with aerosolized nasal dexamethasone phosphate versus placebo. Ann Allergy. 1982;49:81–5.PubMedGoogle Scholar
  7. 7.
    Danner C. Middle ear atelectasis: what causes it and how is it corrected? Otolaryngol Clin North Am. 2006;39:1211–19.PubMedCrossRefGoogle Scholar
  8. 8.
    Friedman RA, Doyle W, Casselbrant M, Bluestone C, Fireman P. Immunological-mediated eustachian tube obstruction: a double-blind crossover study. J Allergy Clin Immunol. 1993;71:442–7.CrossRefGoogle Scholar
  9. 9.
    Skoner D, Doyle WJ, Fireman P. Eustachian tube obstruction (ETO) after histamine nasal provocation—a double blind dose response study. J Allergy Clin Immunol. 1987;79:27–31.PubMedCrossRefGoogle Scholar
  10. 10.
    Skoner DP, Lee L, Doyle WJ, Chamowitz A, Fireman P. Eustachian tube obstruction (ETO) after intranasal challenge with house dust mite. Arch Otolaryngol. 1986;112:840–2.CrossRefGoogle Scholar
  11. 11.
    Bernstein J. Role of allergy in eustachian tube blockage and otitis with effusion: a review. Otolaryngol Head Neck Surg. 1996;114:562–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Mattucci K, Barak G. Middle ear effusion-allergy relationships. Ear Nose Throat J. 1995;74:752–8.PubMedGoogle Scholar
  13. 13.
    Stenstrom C, Bylander-Groth A, Ingvarsson L. Eustachian tube function in otitis prone and healthy children. Int J Pediatr Otorhinolaryngol. 1991;21:127–38.PubMedCrossRefGoogle Scholar
  14. 14.
    Kraemmer M, Marshaal S, Richardson M. Aetiological factors in the development of chronic middle ear effusions. Clinical Rev Allergy. 1984;2:319–28.Google Scholar
  15. 15.
    Yeo S, Park D, Eun Y, Cha C. The role of allergic rhinitis in the development of otitis media with effusion: effect on eustachian tube function. Am J Otolaryngol. 2007;28(3):148–52.PubMedCrossRefGoogle Scholar
  16. 16.
    Martines F, Martinciglio G, Martines E, Bentivegna D. The role of atopy in otitis media with effusion among primary school children: audiological investigation. Eur Arch Otorhinolaryngol. 2010;267(11):1673–8. Epub 2010 Jun 9.PubMedCrossRefGoogle Scholar
  17. 17.
    Gultekin E, Develioğlu ON, Yener M, Ozdemir I, Külekçi M. Prevalence and risk factors for persistent otitis media with effusion in primary school children in Istanbul, Turkey. Auris Nasus Larynx. 2010;37(2):145–9. Epub 2009 Jun 21.PubMedCrossRefGoogle Scholar
  18. 18.
    •• Karagama Y, Rashid M, Lancaster J, Karkanevatos A, William R. Intranasal delivery of drugs to eustachian tube orifice. J Laryngol Otol. 2011;125(9):934–9. This prospective five period cross-over study was published in 2011 and is the first to address the issue of optimal head position. It is postulated that the efficacy of intranasal delivery can only be ascertained if maximal delivery is achieved.PubMedCrossRefGoogle Scholar
  19. 19.
    Thomas C, Simpson S, Butler C, van der Voort J. Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev. 2006;3CD001935Google Scholar
  20. 20.
    Cengel S, Akyol M. The role of topical nasal steroids in the treatment of children with otitis media with effusion and/or adenoid hypertrophy. Int J Pediatr Otorhinolaryngol. 2006;70(4):639–45. Epub 2005 Sep 16.PubMedCrossRefGoogle Scholar
  21. 21.
    •• Gluth M, McDonald D, Weaver A, Bauch C, Beatty C, Orvidas L. Management of eustachian tube dysfunction with nasal steroid spray: a prospective, randomized, placebo-controlled trial. Arch Otolaryngol Head Neck Surg. 2011;137(5):449–55. This randomized, placebo-controlled, double-blind prospective clinical trial was published in 2011 to determine the efficacy of intranasal steroids in treating the tympanometric signs and symptoms of eustachian tube dysfunction. No statistical difference was demonstrated between active and placebo arms.PubMedCrossRefGoogle Scholar
  22. 22.
    Jackson L, Light J, Rosenberg S, Silverstein H, Thompson J. Direct application of dexamethasone for the treatment of chronic eustachian tube dysfunction. ENT J. 2003;82(1).Google Scholar
  23. 23.
    Karlidağ T, Kaygusuz I, Gök U, Yalçin S, Keleş E, Oztürk L. The efficacy of combining antibiotic treatment with topical intranasal steroid administration in the treatment of chronic otitis media with effusion. Kulak Burun Bogaz Ihtis Derg. 2002;9(4):257–62.PubMedGoogle Scholar
  24. 24.
    Moran D, Mutchie K, Higbee M, Paul D. The use of antihistamine-decongestant in conjunction with an anti-infective drug in the treatment of acute otitis media. J Pediatr. 1982;101(1):132–6.PubMedCrossRefGoogle Scholar
  25. 25.
    Stillwagon P, Doyle W, Fireman P. Effect of an antihistamine/decongestant on nasal and eustachian tube function following intranasal pollen challenge. Ann Allergy. 1987;58(6):442–6.PubMedGoogle Scholar
  26. 26.
    van Heerbeek N, Ingels K, Rijkers G, Zielhuis G. Therapeutic improvement of eustachian tube function: a review. Clin Otolaryngol Allied Sci. 2002;27(1):50–6.PubMedCrossRefGoogle Scholar
  27. 27.
    Cantekin E, Mandel E, Bluestone C, Rockette H, Paradise J, Stool S, et al. Lack of efficacy of a decongestant-antihistamine combination for otitis media with effusion (“secretory” otitis media) in children: results of a double-blind, randomized trial. N Engl J Med. 1983;308(6):297–301.PubMedCrossRefGoogle Scholar
  28. 28.
    Turner R, Darden P. Effect of topical adrenergic decongestants on middle ear pressure in infants with common colds. Pediatr Infect Dis J. 1996;15(7):621–4.PubMedCrossRefGoogle Scholar
  29. 29.
    Oshima T, Kikuchi T, Kawase T, Kobayashi T. Nasal instillation of physiological saline for patulous eustachian tube. Acta Otolaryngol. 2010;130(5):550–3.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  1. 1.South West DeaneryRoyal Devon and Exeter HospitalExeterUK

Personalised recommendations